Comparison analysis in synchronous and metachronous metastatic colorectal cancer based on microarray expression...

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Colorectal cancer (CRC) is a leading cause of cancer death, with liver metastasis being a primary driver.
• Understanding the molecular differences between synchronous (SC) and metachronous (MC) colorectal cancer lesions is crucial for improving treatment strategies.
• Investigating the genetic underpinnings of CRC metastasis can reveal novel therapeutic targets.

Purpose of the Study:

• To compare the genetic differences between metachronous (MC) and synchronous (SC) colorectal cancer lesions.
• To explore the molecular pathology associated with colorectal cancer metastasis.
• To identify differentially expressed genes (DEGs) involved in CRC progression.

Main Methods:

• Utilized microarray expression profile data (GSE10961) from the Gene Expression Omnibus database.
• Identified differentially expressed genes (DEGs) between 8 MC and 10 SC samples using T-tests.
• Performed Gene Ontology (GO) enrichment analysis on down-regulated DEGs and conducted Classify validation of known CRC genes.

Main Results:

• Identified a total of 36 DEGs, with 35 down-regulated and 1 up-regulated between MC and SC samples.
• Observed minimal expressional differences in key oncogenes (EGFr, PIK3R1, PTGS2, PTGS1, ALOX5AP) between SC and MC.
• Highlighted potential roles for DEGs such as NFAT5, OLR1, ERAP2, HOXC6, and TWIST1 in CRC metastasis regulation.

Conclusions:

• Specific DEGs, including NFAT5, OLR1, ERAP2, HOXC6, and TWIST1, may be critical in regulating colorectal cancer metastasis.
• These identified genes might influence CRC progression by disrupting specific molecular pathways.
• The findings necessitate further experimental validation to confirm the role of these DEGs in colorectal cancer metastasis.